{
  "trial_id": "NCT02492347",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Neonates 37 weeks or more gestation at birth",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Age of parent/ person with parental responsibility being at least 16 years old",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Clinically well parent/ person with parental responsibility",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "English Speaking parent/ person with parental responsibility",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Neonate at least 48 hours old",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Maternal SSRI use at any point in pregnancy",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Neonates less than 37 weeks gestation at birth",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Age of parent/ person with parental responsibility under 16 years old",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "Patient has history of acne and mild hirsutism, elevated testosterone levels, gradual enlargement of hands and feet, irregular menstrual cycle, nipple discharge, snoring, headache, facial features of acromegaly and prognathism. Laboratory evaluation reveals IGF-1 of 968 ng/mL and random GH of 19.7 ng/mL.",
  "_meta": {
    "topic_id": "20",
    "trial_id": "NCT02492347",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}